title: Hypothesis-based weight-of-evidence evaluation of the neurodevelopmental effects of chlorpyrifos.
abstract: We used a hypothesis-based weight-of-evidence (HBWoE) approach to analyze the evidence regarding the hypothesis that chlorpyrifos can cause neurodevelopmental effects below the threshold for inhibition of acetylcholinesterase activity in the nervous system, which is an established mode of action for chlorpyrifos neurotoxicity. The epidemiology data do not consistently demonstrate associations between chlorpyrifos exposure and neurodevelopmental toxicity, and the animal toxicity data do not provide clear evidence that neurodevelopmental effects occur at doses below the threshold for acetylcholinesterase inhibition. The alternative mechanisms proposed to underlie potential neurodevelopmental effects in humans have been observed in the absence of acetylcholinesterase inhibition in a few in vitro studies but not in the developing brain in vivo. We provide perspective on the HBWoE approach compared with frameworks developed by the United States Environmental Protection Agency and the European Center for Ecotoxicology and Toxicology of Chemicals. We suggest that our HBWoE approach offers advantages over these frameworks in providing a better perspective on how to integrate all of the relevant data and how to use each line of evidence to inform the integration of other kinds of data or compare alternative hypotheses. Based on an HBWoE analysis, we conclude that a causal association between chlorpyrifos exposure and neurodevelopmental effects in the absence of acetylcholinesterase inhibition in the brain is not plausible in humans, and the few positive associations observed in epidemiology studies are most likely attributable to alternative explanations.
authors.affiliation: Gradient, Cambridge, Massachusetts 02138, USA.
authors.forename: Robyn L
authors.initials: RL
authors.lastname: Prueitt
authors.forename: Julie E
authors.initials: JE
authors.lastname: Goodman
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Bailey
authors.forename: Lorenz R
authors.initials: LR
authors.lastname: Rhomberg
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D004390:Chlorpyrifos / Q000493:pharmacokinetics / Q000633:toxicity*; D002800:Cholinesterase Inhibitors / Q000493:pharmacokinetics / Q000633:toxicity*; D054750:Ecotoxicology / Q000379:methods; D016021:Epidemiologic Studies; D005060:Europe; D006801:Humans; D009420:Nervous System / Q000187:drug effects* / Q000378:metabolism; D020258:Neurotoxicity Syndromes / Q000473:pathology; D014481:United States
chemical_list: D002800:Cholinesterase Inhibitors; D004390:Chlorpyrifos